SLP
Simulations Plus Inc.
Halal Rating :
Last Price
$29.92
Last updated:
Market Cap
$601.17m
7D Change
3.53%
1 Year Change
-26.05%
Company Overview
Industries
Exchange
Nasdaq
Next Earnings Date
Simulations Plus, Inc. develops and produces software for modeling molecular properties, pharmacology, metabolism, toxicology, and biosimulation for drug discovery and development. The company provides software solutions and consulting services to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies.
Their primary business involves developing simulation and modeling software that helps pharmaceutical companies optimize their drug development process, potentially reducing the time and cost of bringing new drugs to market.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Nov. 30, 2024 | $18.92m | $18.8m | - | - | 0.00% | 0.00% |
| Aug. 31, 2024 | $18.66m | $19.82m | - | - | 0.00% | 0.00% |
| May 31, 2024 | $18.54m | $16.66m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Simulations Plus Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.